Sign up to save your podcasts
Or
Share For Pharmacists: Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
For Pharmacists: Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma
Did you know that HER2-targeted therapy is an established treatment option for patients with HER2-positive metastatic gastric/gastroesophageal junction (GEJ) cancer?
Credit available for this activity expires: 4/16/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000688?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape
4.3
2525 ratings
Did you know that HER2-targeted therapy is an established treatment option for patients with HER2-positive metastatic gastric/gastroesophageal junction (GEJ) cancer?
Credit available for this activity expires: 4/16/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000688?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current CME
View all
JAMA Editors' Summary
134 Listeners
AFP: American Family Physician Podcast
696 Listeners
JAMA Clinical Reviews
498 Listeners
JACC This Week
170 Listeners
Diabetes Core Update
101 Listeners
This Week in Cardiology
884 Listeners
The Bob Harrington Show
13 Listeners
One-on-One with Eric Topol
17 Listeners
Mayo Clinic Talks
290 Listeners
Frankly Speaking About Family Medicine
260 Listeners
The Curbsiders Internal Medicine Podcast
3,336 Listeners
Core IM | Internal Medicine Podcast
1,154 Listeners
Annals On Call Podcast
195 Listeners
JAMA Medical News
90 Listeners
The Clinical Problem Solvers
512 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
365 Listeners
Freely Filtered, a NephJC Podcast
172 Listeners
Medicine and the Machine
61 Listeners
Keeping Current
8 Listeners
Cardionerds: A Cardiology Podcast
431 Listeners